Media

Author: Schneider Wallace

Class Plaintiffs Settle With Bausch, Lupin, and Assertio for Glumetza

On September 22, 2021 U.S. District Judge William Alsup preliminarily approved settlements with Bausch Health Cos. Inc., Lupin Pharmaceuticals Inc. and Assertio Therapeutics Inc. worth $454 million.

Major Pharmacy Chains Join cART Antitrust Litigation

On September 22, 2021, CVS, Rite Aid, Walgreen, Kroger, Albertsons, and H.E.B. filed direct purchaser actions alleging an anticompetitive conspiracy to monopolize the market for combination antiretroviral therapy (“cART”) drugs used to treat HIV infection in the U.S. District Court for the Northern District of California.

Teva Copaxone Kickback Suit Overcomes Motion to Dismiss

On September 9, 2021, the U.S. District Court for the District of Massachusetts mostly denied a motion to dismiss a DOJ action alleging that Teva willfully violated the Anti-Kickback statute through copayment assistance donations that ended up exclusively subsidizing prescriptions for its multiple sclerosis drug, Copaxone. The court found that the government had alleged in sufficient detail a scheme by which Teva practically guaranteed that its own donations would result in the submission of Medicare claims for Copaxone.

Lawsuit Alleging Manipulation of Crypto Markets Through Unbacked Stablecoin “Tether” Survives Motion to Dismiss

A class of cryptocommodities purchasers represented by Selendy & Gay PLLC, Roche Freedman LLP, and Schneider Wallace Cottrell Konecky LLP will be allowed to proceed with a lawsuit alleging a conspiracy to manipulate the crypto markets, following a decision on the defendants’ motion to dismiss issued on September 28, 2021.

Schneider Wallace Victory Over Forced Arbitration Upheld by 6th Circuit Court of Appeals

On August 4, 2021, the 6th U.S. Circuit Court of Appeals agreed with a lower court ruling that a Schneider Wallace represented gas station employee was not subject to forced arbitration, and that the employee can pursue a wage-and-hour class action in court. The three-judge panel held unanimously that the Schneider Wallace case can proceed despite the fact that Defendant claimed that it was subject to mandatory arbitration, because the court found that the language in the Newcomb Oil Co LLC’s employee handbook was not enforceable under the Federal Arbitration Act.

Amy Eskin of Schneider Wallace Appointed State Court Liaison Counsel for California in Paraquat MDL

Chief Judge Nancy J. Rosenstengel of the United States District Court for the Southern District of Illinois appointed Amy Eskin of Schneider Wallace Cottrell Konecky LLP as State Court Liaison Counsel for California and a member of the 15 member Plaintiffs’ Executive Committee supervising  the In re Paraquat Products Liability Litigation. MDL No. 3004.

Schneider Wallace Wins Another Victory for Students With Disabilities

On July 8, 2021, the United States Court of Appeals for the Second Circuit affirmed the judgment of the United States District Court for the District of Connecticut, holding that Connecticut violated the Individuals With Disabilities Act (“IDEA”) by terminating special education services for students prior to their 22nd birthday while offering public education to non-disabled adults. They also held that Connecticut’s violation entitled class members who are no longer receiving special education to compensatory education to remedy the past unlawful termination of their services.

Prudential Security Hit with Wage and Hour Class Action Brought by Security Guard Employees

Prudential Security faces a lawsuit brought by security guards represented by Schneider Wallace Cottrell Konecky for the company’s alleged unlawful wage and hour policies and practices. The class action complaint was filed in Illinois state court, Cook County on April 6, 2021.

Appeals Court Reverses Dismissal of Tracleer Class Action

The Fourth Circuit reversed the dismissal of an antitrust class action alleging Actelion unlawfully monopolized the Tracleer market.

District Court Approves Partial Settlement in Surescripts Class Action 

The Northern District of Illinois preliminarily approved a $10 million class action settlement by RelayHealth in Surescripts e-prescription antitrust lawsuit.